About Contraceptives Contraception, also known as birth control or fertility control, refers to the use of methods or drugs or devices to prevent pregnancy as a consequence of sexual intercourse. Contraception methods can be temporary and permanent and are available to men and women. Permanent methods include male sterilization (vasectomy), and female sterilization including tubal occlusion or hysteroscopic sterilisation. Temporary methods can be hormonal and non-hormonal. The non-hormonal methods include condoms, diaphragms, sponges, withdrawal methods, cervical caps, and non-hormonal IUDs. Condoms, diaphragms, sponges, and cervical caps are also referred to as barrier contraception methods. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. Hormonal methods contain synthetic sex hormones estrogen/progestin or a combination of both which prevent ovulation and thicken cervical mucus in the female. Currently, hormonal methods can only be used by women. The development of a male hormonal contraceptive is an active research area. Research Beam Model: Research Beam Product ID: 17974 2500 USD New
Global Contraceptives Market 2014-2018
 
 

Global Contraceptives Market 2014-2018

  • Category : Healthcare
  • Published On : June   2014
  • Pages : 109
  • Publisher : Technavio
 
 
 

About Contraceptives 

Contraception, also known as birth control or fertility control, refers to the use of methods or drugs or devices to prevent pregnancy as a consequence of sexual intercourse. Contraception methods can be temporary and permanent and are available to men and women. Permanent methods include male sterilization (vasectomy), and female sterilization including tubal occlusion or hysteroscopic sterilisation. Temporary methods can be hormonal and non-hormonal. The non-hormonal methods include condoms, diaphragms, sponges, withdrawal methods, cervical caps, and non-hormonal IUDs. Condoms, diaphragms, sponges, and cervical caps are also referred to as barrier contraception methods. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. Hormonal methods contain synthetic sex hormones estrogen/progestin or a combination of both which prevent ovulation and thicken cervical mucus in the female. Currently, hormonal methods can only be used by women. The development of a male hormonal contraceptive is an active research area.

TechNavio's analysts forecast the Global Contraceptives market will grow at a CAGR of 5.90 percent over the period 2013-2018.

Covered in this Report

The Global Contraceptives market can be segmented broadly into two divisions: Drugs and Devices. This report covers the present scenario and the growth prospects of the Global Contraceptives market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of various products used for contraception which include:

• Drugs (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives)

• Devices (Male & Female condoms, Diaphragms, IUDs, Vaginal Rings, Female Sponges and Subdermal Contraceptive Implants)

TechNavio's report, the Global Contraceptives Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Contraceptives market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas 

• EMEA        

• APAC

Key Vendors

• Actavis plc

• Bayer AG 

• Johnson & Johnson’s Janssen Pharmaceuticals, Inc.

• Merck & Co.

• Pfizer, Inc.

• Teva Pharmaceutical Industries, Ltd

Other Prominent Vendors

 

• Adamis Pharmaceuticals

• Corp.

• Agile Therapeutics, Inc.

• ANI Pharmaceuticals, Inc.

• Ansell Ltd.

• Apothecus Pharmaceutical Corp.

• Blairex Laboratories Inc.

• Church & Dwight, Co. Inc.

• Caldwell Consumer Health, LLC.

• Ferring International Center S.A

• Fuji Latex Co., Ltd.

• HLL Lifecare Limited

• Mayer Laboratories 

• Medicines 360

• Karex Berhad  

• Lipocine Inc.

• Lupin Pharmaceuticals, Inc.

• Mylan Laboratories Inc.

• Okamoto Industries, Inc.

• Pantarhei Bioscience B.V.

• Paul Hartmann AG

• Reckitt Benckiser Group Plc

• The Female Health Company



Key Market Driver

• Growing Prevalence of Unwanted Pregnancies.

• For a full, detailed list, view our report.

Key Market Challenge

• Growing Prevalence of Unwanted Pregnancies. 

• Introduction of Cheap Generic Contraceptives 

• For a full, detailed list, view our report.

Key Market Trend

• Increasing Strategic Partnerships.

• For a full, detailed list, view our report.

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


 



 


01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

     03.1 Market Overview

     03.2 Product Offerings

04. Market Research Methodology

    04.1 Market Research Process

    04.2 Research Methodology

05. Introduction

06. Market Landscape


    06.1 Market Overview

    06.2 Market Size and Forecast

    06.3 Five Forces Analysis

07. Market Segmentation by Products Type

    07.1.1 Drugs

    07.1.2 Devices

    07.1.3 Comparison of Different Types of Contraceptives

08. Global Contraceptives Drugs Market

   08.1 Market Size and Forecast of Contraceptives Drugs

   08.2 Global Oral Contraceptives Pills Market

   08.2.1 Market Size and Forecast of Oral Contraceptives Pills

   08.3 Global Injectable Contraceptives Market

   08.3.1 Market Size and Forecast of Injectable Contraceptives

   08.4 Global Topical Contraceptives Market

   08.4.1 Market Size and Forecast of Topical Contraceptives

09. Global Contraceptives Devices Market

   09.1 Market Size and Forecast of Contraceptives Devices

   09.2 Global Condoms Market

   09.2.1 Market Size and Forecast of Condoms

   09.3 Global IUDs Market

   09.3.1 Market Size and Forecast of IUDs

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Vendor Landscape


  19.1 Competitive Scenario

  19.1.1 Key News

  19.1.2 Mergers and Acquisitions

  19.2 Market Share Analysis 2013

  19.3 Other Prominent Vendors

20. Key Vendor Analysis

21. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Contraceptives Market 2013-2018 (US$ billion)

Exhibit 3: Global Contraceptives Market Segmentation by Product Type

Exhibit 4: Global Contraceptives Market by Product Type 2013

Exhibit 5: Global Contraceptives Market Segmentation by Product Type

Exhibit 6: Global Contraceptives Drugs Market Segmentation

Exhibit 7: Global Contraceptives Drugs Market 2013-2018 (US$ billion)

Exhibit 8: Global Oral Contraceptives Pills Market 2013-2018 (US$ billion)

Exhibit 9: Global Injectable Contraceptives Market 2013-2018 (US$ billion)

Exhibit 10: Global Topical Contraceptives Market 2013-2018 (US$ billion)

Exhibit 11: Global Contraceptives Drugs Market 2013-2018 (US$ billion)

Exhibit 12: Global Contraceptives Drugs Market 2013-2018 (Revenue in Percentage)

Exhibit 13: Global Contraceptives Devices Market Segmentation

Exhibit 14: Global Contraceptives Devices Market 2013-2018 (US$ billion)

Exhibit 15: Global Condoms Market 2013-2018 (US$ billion)

Exhibit 16: Global Contraceptives Market by Geographical Segmentation (Revenue in Percentage)

Exhibit 17: Snapshot of Global Contraceptives Market Pipeline 2013

Exhibit 18: Licensing Agreements in Global Contraceptives Market (in Percentage)


 



 



PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 

Related Reports

REQUEST SAMPLE    ASK FOR DISCOUNT